The law firm of Kirby McInerney LLP is investigating potential claims against Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ:SYM). The investigation concerns whether Symbotic and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

[Click here to learn more about the investigation]

On November 27, 2024, before the market opened, Symbotic announced it would not be able to file its Annual Report on Form 10-K for the fiscal year ended September 28, 2024, with the U.S. Securities and Exchange Commission. Symbotic disclosed that on November 25, 2024, it had identified errors in its revenue recognition related to cost overruns that are not billable on certain deployments, which additionally impacted system revenue recognized in the first three quarters of fiscal year 2024. The total impact of the errors will lower system revenue, system gross profit, income (loss) before income tax, and adjusted EBITDA by $30 to $40 million for fiscal year 2024. Furthermore, Symbotic lowered its fiscal year 2025 revenue and EBITDA guidance by 3.0% and 51.7%, respectively. On this news, the price of Symbotic shares declined by $13.41 per share, or approximately 35.8%, from $37.41 per share on November 26, 2024, to close at $24.00 on November 27, 2024.

If you purchased or otherwise acquired Symbotic securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241202283767/en/